InSpire MD to Participate in Benchmark Investor Conference on May 30th
5/24/2013 7:34:14 AM
More...
|
InSpire MD Announces Reimbursement Coverage for MGuard™ Coronary
5/17/2013 9:05:40 AM
More...
|
InSpire MD to Announce Six-Month Results From The MGuard™ Embolic Protection Stent (EPS) MASTER Trial at EuroPCR
5/17/2013 6:57:34 AM
More...
|
InSpire MD Reports Financial Results For Period Ended March 31, 2013
5/8/2013 7:26:03 AM
More...
|
InSpire MD Receives Approval From FDA to Begin US Regulatory Trial
4/23/2013 9:59:30 AM
More...
|
InSpire MD Hires Vice President of Corporate Development
4/19/2013 9:08:54 AM
More...
|
InSpire MD Closes $25 Million Underwritten Public Offering
4/17/2013 7:24:15 AM
More...
|
InSpire MD Announces Pricing of Underwritten Public Offering of Common Stock and Listing on NYSE MKT
4/11/2013 9:39:26 AM
More...
|
InSpire MD Receives CE Mark Approval for Carotid Embolic Protection Stent
3/18/2013 7:30:38 AM
More...
|
InSpire MD Receives CE Mark Approval for Carotid Embolic Protection Stent
3/15/2013 9:57:56 AM
More...
|
|